Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Al Razi Medical Co's interest expense for the
six
months ended in Jun. 2026 was ﷼ 0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼0.00 Mil.
Al Razi Medical Co (SAU:9572) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Al Razi Medical Co's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as
GuruFocus does not calculate Al Razi Medical Co's interest coverage with the available data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Al Razi Medical Co Interest Expense Historical Data
* Premium members only.
The historical data trend for Al Razi Medical Co's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Al Razi Medical Co (SAU:9572) has a Interest Expense of ﷼0.00 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Al Razi Medical Co and its competitors.
Is Al Razi Medical Co's Interest Expense too high?
Al Razi Medical Co's current Interest Expense is ﷼0.00 Mil. Overall, Al Razi Medical Co has a GF Score™ of 39/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al Razi Medical Co's Interest Expense compare to competitors?
Al Razi Medical Co's Interest Expense of ﷼0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Al Razi Medical Co and its competitors. Al Razi Medical Co's current Interest Expense is ﷼0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al Razi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Al Razi Medical Co (SAU:9572) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼57.15, compared to a current price of ﷼26.60 — trading 53.5% below its estimated fair value. The current Interest Expense is ﷼0.00 Mil. Al Razi Medical Co's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Al Razi Medical Co (SAU:9572), the current Interest Expense is ﷼0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al Razi Medical Co (SAU:9572) Overvalued in 2026?
Based on GuruFocus' analysis, Al Razi Medical Co stock appears to be undervalued.
The current stock price of ﷼26.60 is trading 53.5% below its estimated GF Value™ of ﷼57.15.
GuruFocus considers Al Razi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:9572:
Interest Expense: ﷼0.00 Mil
GF Value™: ﷼57.15 vs. price of ﷼26.60 (53.5% below fair value)
No single metric tells the full story. See the SAU:9572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al Razi Medical Co operates in the medical field in the Kingdom of Saudi Arabia. The company provides all pharmaceutical and cosmetic products. It engages in buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis.
39GF Score
Get the complete analysis for SAU:9572
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9572 has been successfully added to your 
